Best Etf To Buy 2018 Direct

Healthcare often acts as a "defensive" sector during volatility. In 2018, breakthroughs in gene therapy boosted specific biotech ETFs. iShares Nasdaq Biotechnology ETF (IBB)

As rates rose, "cash-like" ETFs finally started providing a modest yield without the drama of the stock market. Review Summary: Was 2018 a good year to buy? 2018 Context Long-term Verdict Broad Market (VOO/VTI) Rough end to the year (-4% approx). best etf to buy 2018

Buying the 2018 dip led to massive gains in 2019-2021. Tech (QQQ) Volatile, but stayed flat/positive. Winner. The dominant theme of the last decade. Dividends (VYM) Struggled due to rising rates. Moderate. Better for income than raw growth. The "Best" Pick in Hindsight Healthcare often acts as a "defensive" sector during

As of , we can evaluate these 2018 picks with the benefit of hindsight to see which ones stood the test of time. Top ETF Categories of 2018 Review Summary: Was 2018 a good year to buy

Because 2018 saw the S&P 500 end the year with a slight loss, some of the "best" ETFs were actually those that preserved capital. iShares Short Treasury Bond ETF (SHV)